Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

B Cell Depletion With the Anti-CD20 Monoclonal Antibody Rituximab in the Treatment of Graves' Disease

NCT00150111 is registered in ClinicalTrials.gov with Odense University Hospital as lead sponsor.

NCT NCT00150111
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00150111 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
B Cell Depletion With the Anti-CD20 Monoclonal Antibody Rituximab in the Treatment of Graves' Disease
Lead sponsor
Odense University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
June 30, 2003
Completion date
October 31, 2006
Enrollment
20
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

graves´ disease, thyroid associated ophthalmopathy